my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Deal watch: Bristol-Myers Squibb invests in cancer antibody that targets the innate immune system
Nature Reviews Drug Discovery 10, 648 (2011). doi:10.1038/nrd3537
Bristol-Myers Squibb has acquired exclusive global rights to Innate Pharma's cancer candidate IPH 2102, which is in Phase I clinical trials for acute myeloid leukaemia (AML). Innate Pharma will receive US$35 million upfront and is eligible to receive up to $430 million in milestones.IPH
| Journal: | Nature Reviews Drug Discovery | |
| Year: | 2011 | |
| DOI: | 10.1038/nrd3537 | |
| Publication date: | 31-08-2011 |
Watchlist
This is where you can add this publication to your personal favourites.
Additional Information
BCL-2 family member BOK is widely expressed but its loss has only minimal impact in mice
BCL-2 family member BOK is widely expressed but its loss has only minimal impact in mice Cell Death and Differentiation 20, 183 (January 2013). doi:10.1038/cdd.2012.143 Authors: F Ke, A Voss, J B Kerr, L A O'Reilly, L Tai, N Echeverry, P Bouillet, A Strasser ... more
A guide to cancer genetics in clinical practice
A guide to cancer genetics in clinical practice European Journal of Human Genetics 21, 120 (January 2013). doi:10.1038/ejhg.2011.69 Author: Dominique Stoppa-Lyonnet more
Towards quantitative cell biology
Nature Cell Biology 14, 1233 (2012). doi:10.1038/ncb2648 Authors: Prisca Liberali & Lucas Pelkmans Cell biologists must decide whether to embrace the maturing field of systems biology. We argue that a fusion of the two is urgently needed to strengthen both fields. more
Olympus Microscopy has partnered with the Nature Publishing Group to present the Neurotechniques Collection. This compilation of articles will draw together some of the groundbreaking research that has recently been published in Nature Reviews Neuroscience and Nature Methods. Sponsored by O ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
